Emmanuel J Favaloro/LinkedIn
Jan 17, 2026, 04:58
Desmopressin in Bleeding Disorders: 5,000 Views in 6 Months – Why This Topic Matters
Emmanuel J Favaloro, Lead Scientist of Sydney Centres for Thrombosis and Haemostasis, shared on LinkedIn:
“A Review of Desmopressin Use in Bleeding Disorders. Nearly 5000 article views in only 6 months. Aiming for 10,000 by it’s one year anniversary.
Free to download from here .”
Title: A Review of Desmopressin Use in Bleeding Disorders: An Unsung Hero?
Authors: Benjamin Reardon, Leonardo Pasalic, Emmanuel J. Favaloro
Find more posts featuring Emmanuel J Favaloro on Hemostasis Today.
-
Jan 17, 2026, 05:05Dr Abdul Mannan: Iron Deficiency Can Hide Beta-Thalassaemia Trait
-
Jan 17, 2026, 05:01Fortis Memorial Research Institute, Gurugram Ranked Among the World’s Top 50 Smart Hospitals
-
Jan 17, 2026, 04:59Flora Peyvandi: Factor VIII in Vitro Bioequivalence of Mim8 Haemostatic Effect
-
Jan 17, 2026, 04:58Sifat Jubaira Shares Chylous Blood Clinical Case: Milky Blood Instead of Red
-
Jan 17, 2026, 04:57Automated VWF Multimer Analysis Using Deep Learning for Improved Diagnosis and Classification of vWD
-
Jan 17, 2026, 04:55Trends in Catheter-Directed Therapy and In-Hospital Outcomes in Acute PE
-
Jan 17, 2026, 04:54Antithrombin III Deficiency – Explained by Astha Thakkar
-
Jan 17, 2026, 04:53Antiphospholipid Syndrome: Not All Antibodies Are Created Equal
-
Jan 17, 2026, 04:53FDA Approval of Mitapivat: Redefining Thalassemia Management